Neurotensin analogs by fluoroglycosylation at N
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
24
05
2022
accepted:
26
08
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Since neurotensin (NT) receptors of subtype-1 (NTS1) are expressed by different types of malignant tumors, such as pancreatic adenocarcinoma, colorectal and prostate carcinoma, they represent an interesting target for tumor imaging by positron emission tomography (PET) and endoradiotherapy. Previously reported neurotensin-derived NTS1 ligands for PET were radiolabeled by modification and prelongation of the N-terminus of NT(8-13) peptide analogs. In this study, we demonstrate that modifying Arg
Identifiants
pubmed: 36056076
doi: 10.1038/s41598-022-19296-0
pii: 10.1038/s41598-022-19296-0
pmc: PMC9440028
doi:
Substances chimiques
Receptors, Neurotensin
0
Neurotensin
39379-15-2
Arginine
94ZLA3W45F
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15028Informations de copyright
© 2022. The Author(s).
Références
Nat Rev Nephrol. 2017 Sep;13(9):580-593
pubmed: 28757635
Pharmacol Rev. 2001 Dec;53(4):453-86
pubmed: 11734615
ACS Med Chem Lett. 2010 May 21;1(5):224-8
pubmed: 24900199
Sci Rep. 2019 Sep 10;9(1):12990
pubmed: 31506520
Biochimie. 2011 Sep;93(9):1369-78
pubmed: 21605619
Am J Physiol Renal Physiol. 2021 Jan 1;320(1):F114-F129
pubmed: 33283642
Bioconjug Chem. 2009 Aug 19;20(8):1602-10
pubmed: 19610615
Front Neuroendocrinol. 1997 Apr;18(2):115-73
pubmed: 9101258
Front Endocrinol (Lausanne). 2013 Jan 17;3:184
pubmed: 23335914
ACS Med Chem Lett. 2019 Sep 30;11(3):334-339
pubmed: 32184966
Biochem Biophys Res Commun. 1994 Aug 30;203(1):465-71
pubmed: 7521165
Angew Chem Int Ed Engl. 2010;49(5):976-9
pubmed: 20029856
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
J Med Chem. 2016 Mar 10;59(5):1925-45
pubmed: 26824643
J Med Chem. 2016 Jul 14;59(13):6480-92
pubmed: 27336295
EJNMMI Res. 2015 Mar 24;5:17
pubmed: 25859423
Pharmaceuticals (Basel). 2021 Nov 17;14(11):
pubmed: 34832957
Gut. 1998 Apr;42(4):546-50
pubmed: 9616318
Nucl Med Biol. 2002 Apr;29(3):321-7
pubmed: 11929702
J Nucl Med. 2020 Dec;61(12):1806-1813
pubmed: 32332144
J Biol Chem. 1973 Oct 10;248(19):6854-61
pubmed: 4745447
Mol Pharm. 2020 Mar 2;17(3):933-943
pubmed: 32011889
Mol Pharm. 2014 Feb 3;11(2):505-15
pubmed: 24325589
ACS Med Chem Lett. 2019 May 10;10(6):960-965
pubmed: 31223455
ACS Med Chem Lett. 2019 Nov 19;11(1):16-22
pubmed: 31938457
Curr Protein Pept Sci. 2014;15(7):681-90
pubmed: 25175457
J Labelled Comp Radiopharm. 2018 Mar;61(3):309-325
pubmed: 29114915
Cancer Res. 2006 Jun 15;66(12):6243-9
pubmed: 16778199
Mol Pharm. 2018 Aug 6;15(8):3093-3100
pubmed: 29889537
Peptides. 2020 Sep;131:170369
pubmed: 32673700
Chem Sci. 2016 Apr 21;7(4):2492-2500
pubmed: 28660018
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E237-45
pubmed: 17405828